앰퍼스타 파마슈티컬스 (AMPH) 주가 전망: 목표주가, 배당, 최신 뉴스

Amphastar Pharmaceuticals, Inc. , a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose.

The company also provides Cortrosyn, a lyophilized power for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; and emergency syringe products, including atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate.

In addition, it offers Albuterol sulfate inhalation aerosol for the treatment or prevention of bronchospasm; Iron sucrose injection, an iron replacement product for the treatment of iron deficiency anemia in patients with chronic kidney disease; Teriparatide injection for managing daily osteoporosis therapy; and Ipratropium Bromide HFA inhalation aerosol, an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease.

Further, the company provides active pharmaceutical ingredient (API) products, such as Recombinant Human Insulin and porcine insulin API. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Amphastar Pharmaceuticals, Inc.는 바이오 제약회사로서 미국, 중국, 프랑스에서 제네릭 및 자체 개발된 주사제, 흡입제, 비강용 제형 제품을 개발·제조·마케팅·판매합니다. 주요 제품으로는 중증 저혈당 응급치료용 건식 비강 스프레이 BAQSIMI, 간헐성 천식의 경미한 증상 완화용 에피네프린 흡입제 Primatene MIST, 긴급용 Glucagon 주사 키트, 심부정맥혈전증 예방·치료용 저분자 헤파린 Enoxaparin, 그리고 REXTOVY 및 오피오이드 과다복용 대응용 Naloxone 등이 있습니다.

진단·치료용 제품으로는 부신피질기능저하 선별용 진단제 Cortrosyn(동결건조 분말), 소에서 유래한 히알루로니다제 Amphadase, 알레르기 반응용 Epinephrine 주사, 비뇨기술용 Lidocaine jelly 및 다양한 처치용 Lidocaine 국소용액, 신생아용 비타민 K1 주사 Phytonadione 등이 있으며, 응급주사 키트용 atropine, calcium chloride, dextrose, epinephrine, lidocaine, sodium bicarbonate 등도 제공합니다.

또한 기관지경련 치료·예방용 Albuterol sulfate 흡입 에어로졸, 만성 신장질환 환자의 철분결핍 빈혈 치료용 Iron sucrose 주사, 일상적 골다공증 관리를 위한 Teriparatide 주사, 만성폐쇄성폐질환의 기관지경련 유지 치료용 Ipratropium Bromide HFA 흡입 에어로졸 등을 보유하고 있으며, Recombinant Human Insulin 및 porcine insulin API 등 활성약물성분(API)도 공급합니다. 회사는 1996년에 설립되었고 본사는 캘리포니아 Rancho Cucamonga에 있습니다.

• 주소: 11570 6th Street, Rancho Cucamonga, CA 91730, United States

• 전화번호: 909 980 9484

• 웹사이트: https://www.amphastar.com

• 섹터: Healthcare

• 산업: Drug Manufacturers - Specialty & Generic

• 직원 수: 1,976